-
Asian-Pacific indices are posting a mixed cash session. The weekend passed relatively calmly, and moves in both forex and equities remain limited.
-
The U.S. dollar is down 0.10%, similar to the Japanese yen. On the other side are the Australian dollar and the euro. Changes, however, remain within a narrow +/-0.10% range. EURUSD is up 0.12%.
-
Markets are waiting for the Fed decision on Wednesday. A further 25 bp rate cut is currently priced with an 87% probability.
-
Gold is up 0.33% to 4,216 USD per ounce. WTI crude gains 0.18% to 60.20 USD per barrel.
-
Japan’s Q3 GDP was revised to –2.3% annualized (vs –2.0% expected), confirming a weak quarter despite slightly stronger private consumption.
-
China recorded a large November trade surplus of 111.7 billion USD, with exports up 5.9% and a jump in rare-earth metal exports. The data shows Beijing continues to dominate global export competitiveness despite tariffs.
-
The WSJ reports that IBM is close to acquiring Confluent for ~11 billion USD, implying roughly a 37% premium. CFLT shares jumped ~20% after hours, though they remain far below IPO levels.
-
Macron warned China about possible EU tariffs. The French president told Beijing that the EU may take steps similar to the U.S. in the coming months if China does not reduce its growing trade surplus — although unity within the EU remains uncertain.
-
Trump said his relationship with Prime Minister Carney is “very good,” and that trade issues “will be resolved,” while noting that Canada produces many goods the U.S. already manufactures.
BREAKING: BoC holds interest rates unchanged🔎CAD with muted reaction
⌚EURUSD Upside Capped Ahead of Fed
US Open: Wall Street waits for the Fed🗽GE Vernova gains, AeroVironment shares slip
BREAKING: Costs of labor bellow expectations in US!🚨EURUSD muted ↔️
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
